Name: Cancer 2025
Start: 2025-04-16
End: 2025-04-18
Location: Dubai

Conference Information

Welcome Message

Dear Esteemed Participants,

We warmly welcome you to the 4th International Conference on Cancer Research and Treatment, set to take place on April 16-17, 2025, in Dubai, UAE.

The Cancer 2025 Conference marks an important moment in our journey toward advancing cancer research and improving patient care. Over the next two days, we will engage in discussions on breakthrough research, explore new treatment approaches, and delve into the latest oncology developments. This gathering brings together an exceptional group of experts from across the globe, all dedicated to enhancing cancer treatment and transforming patient outcomes.

Dubai, renowned for its dynamic growth and cultural richness, provides an inspiring setting for our discussions. Its iconic cityscape and diverse community foster a vibrant atmosphere for expanding our understanding, creating new collaborations, and envisioning the future of cancer care.

We encourage you to make the most of this opportunity by actively participating in sessions relevant to your field, networking with peers, and sharing forward-thinking ideas that could shape the direction of cancer research and treatment.

We look forward to an enriching and inspiring experience for all.

Best regards,
Marina Jenny
Program Manager
Organizing Committee | Cancer 2025
Email: cancer@pulsusgather.com
WhatsApp: +44 7389644903

Deadlines

Dates to be highlighted for Cancer 2025 Conference

Deadline for Abstract Submission: January 10, 2025
Deadline for Final Paper Submission: January 17, 2025
Deadline for Early Bird Registration: January 24, 2025
Notification of Abstract Acceptance or Rejection: Within 2-3 days.
Conference Dates: April 16-17, 2025
*By Midnight-11:59 pm

Seize the opportunity to attend the Cancer Conference 2025 with our exclusive group registration discount! Gather your colleagues, as groups of five or more will receive a 25% discount on the total registration fee.

But that’s not all-register early to enjoy exclusive early bird benefits. Visit the Cancer 2025 website for full details on early registration perks and group savings.

By registering as a team, you’ll not only save significantly on this premier conference but also gain unparalleled opportunities for professional development, networking, and insight into the latest in cancer research and treatment. Don’t miss this chance to grow together!

Venue

Enjoy a Comfortable Stay at Cancer 2025 with Our Convenient Accommodation Options

Ensure a seamless and enjoyable experience during Cancer 2025 with our tailored accommodation options, designed for both comfort and productivity.

Optimize Your Visit: Take advantage of our flexible check-in and check-out options (subject to room availability) to make the most of your time in Dubai.

Room Options:

Single Occupancy: Choose a single room for a peaceful and private stay.
Double Occupancy: Opt for a double room if you'd like to share the experience with a colleague.

Need Assistance?

For additional room bookings or if you need separate arrangements for colleagues or family, please contact our dedicated team at cancer@pulsusgather.com . Provide us with your preferred package details and the number of nights you need, and we'll assist you promptly. A personalized registration link will be sent to facilitate a smooth booking process.

Confirm Your Stay: To secure your reservation for the desired dates, please make a prompt payment of the applicable fee. You will receive a confirmation email upon payment to ensure your booking is confirmed.

Explore Your Venue: Discover the exciting location and amenities available at the Cancer 2025 Venue Page .

Our team is ready to help with any questions or booking needs you may have. Please contact us at cancer@alliedgathering.com for support.

About

The Cancer Research and Treatment Conference, set to take place on April 16-17, 2025, in the vibrant city of Dubai, UAE, invite a global audience to participate. We’re thrilled to welcome professionals from R&D organizations, Ph.D. scholars, physicians, healthcare providers, advertising firms, research institutions, medical schools, faculties, associations, diagnostic centres, pharmaceutical companies, product development experts, healthcare industries, and medical device manufacturers from across the globe.

Join this esteemed international gathering to delve into the latest advancements, emerging trends, challenges, and solutions in cancer research and treatment. Organized by Pulsus, the conference provides a high-profile platform for sharing knowledge, presenting ground breaking discoveries, and promoting advancements in the field.

With the theme “Advanced Diagnostics and Imaging: Beyond Boundaries” Cancer 2025 aims to drive progress in cancer care through the exchange of ideas, insights, and expertise. Featuring leading speakers, scientists, and researchers from around the world, this event encourages the exploration of innovative ideas and novel approaches in cancer research and treatment.

The conference will include an array of lectures, symposia, workshops, scientific sessions, and poster presentations—creating an ideal environment for meaningful dialogue and advancements in cancer care. Upholding professionalism and excellence, Cancer 2025 is dedicated to supporting progress in the field with dignity and respect.

The Cancer 2025 Conference provides an invaluable opportunity for researchers to expand their work and contribute to the growth of cancer research. We look forward to your contributions and participation in making this event an outstanding success.

Join Us in Dubai!
Be part of the 4th International Conference on Cancer Research and Treatment, and connect with a dynamic community that is passionate about advancing knowledge in cancer research.

Awards:
Outstanding contributors to Cancer 2025 will be recognized with prestigious awards:

Young Scientist Award
Best Speaker Award
Best Poster Award
Best Keynote Speaker Award
Best Organizing Committee Member Award

We look forward to celebrating your contributions and achievements at Cancer 2025!

Abstract Guidelines

Abstract Acceptance Criteria

The Cancer 2025 Conference is calling for abstract submissions for paper and poster presentations. Showcase your innovative research to a global network of cancer care experts.

Abstracts will be evaluated based on the following criteria:

Relevance: Ensure alignment with key conference themes, such as new treatment methods or patient support approaches.
Clarity: Present your research in a clear, concise, and organized manner.
Methodology: For research studies, provide a well-structured design, with transparent data collection and analysis.
Clinical Impact: Highlight insights that have the potential to enhance cancer care.
Innovation: Showcase fresh perspectives or breakthrough approaches in cancer treatment.

Review Process:

Quick Feedback: Receive review results within 48 hours.
Double-Blind: Reviewed anonymously by qualified experts for objectivity.
Constructive: Feedback provided to support research improvements.

Submission Guidelines:

Platform: Submit via the Cancer 2025 website in Word format.
Content: Keep abstracts within 300 words and follow the provided template.
Structure: Organize your submission with sections for Summary, Background, Research Methods, Findings, Analysis, Final Remarks, Credits, and Citations.
Author Info: Provide brief bios (up to 150 words), along with photos and email addresses.

Submit you’re abstract and take part in advancing cancer research at Cancer 2025!

Contact Us: Our team is here to assist with any questions regarding the submission process. For support, please contact us at cancer@pulsusgather.com . We aim to provide timely and helpful responses to ensure a smooth submission experience.

Scientific Sessions

Session 1: Clinical Trials and Research

Cancer research aim to enhance patient care, discovers new therapies, and improves existing medications. These trials are rigorously supervised studies designed to assess the safety, effectiveness, and optimal use of new drugs, treatments, or diagnostic methods.

Track 1-1 Designing Clinical Trials
Track 1-2 Phases of Clinical Trials
Track 1-3 Ethical Considerations
Track 1-4 Data Analysis and Interpretation
Track 1-5 Patient Recruitment and Retention

Session 2: Cancer Treatment

Precision medicine in cancer treatment tailors care to the specific characteristics of each patient’s cancer, such as its molecular, genetic, and phenotypic traits. This approach identifies particular mutations and biomarkers that guide the selection of targeted therapies, ensuring more effective and personalized treatment plans. Advanced diagnostics, including genome sequencing, play a key role in supporting this individualized approach.

Track 2-1 Genomic Profiling
Track 2-2 Tailored Drug Therapies
Track 2-3 Personalized Treatment Plans
Track 2-4 Pharmacogenomics
Track 2-5 Clinical Trials and Data Integration

Session 3: Therapeutic Strategies

Cancer treatment strategies encompass various therapies designed to specifically target and destroy cancer cells. These include radiation therapy, which uses high-energy rays to eliminate tumours; chemotherapy, and targeted therapies.

Track 3-1 Chemotherapy
Track 3-2 Radiation Therapy
Track 3-3 Targeted Therapies
Track 3-4 Immunotherapy
Track 3-5 Hormonal Therapy

Session 4: Cancer Biology

Throughout our lives, our cells are genetically programmed to perform various functions. Cells that become damaged or age naturally die and must be replaced by new ones. A tumour often referred to as a “mass,” result from the uncontrolled proliferation of cells caused by genetic mutations. In the context of cancer, this term signifies the growth of abnormal tissue.

Track 4-1 Genetic Mutations and Their Role in Cancer
Track 4-2 The Tumour Microenvironment
Track 4-3 Oncogenes and Tumour Suppressor Genes
Track 4-4 Cell Signalling Pathways
Track 4-5 Cancer Stem Cells

Session 5: Cancer Genetics

Cancer genetics is the study of genetic changes that drive the initiation and progression of cancer. It examines how both somatic mutations and inherited genetic variations contribute to tumour formation, growth, and spread.

Track 5-1 Inherited Cancer Syndromes
Track 5-2 Genetic Risk Assessment
Track 5-3 Gene Editing Technologies
Track 5-4 Epigenetics and Cancer
Track 5-5 Genetic Counselling

Session 6: Cancer Immunology

This session explores the complex interactions between the immune system and cancer cells, aiming to understand how these relationships influence tumour growth and treatment responses. Key areas of study include how immune cells target cancer, the mechanisms tumours use to evade immune detection, and advancements in immunotherapies such as checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines.

Track 6-1 Tumour Antigens
Track 6-2 Immune Checkpoint Inhibitors
Track 6-3 CAR-T Cell Therapy
Track 6-4 Cancer Vaccines
Track 6-5 Tumour-Infiltrating Lymphocytes

Session 7: Paediatric Oncology

Focused on the diagnosis and treatment of cancer in children and adolescents, paediatric oncology addresses the unique aspects of cancer in younger populations, including distinct tumour types, treatment side effects, and issues related to long-term survivorship.

Track 7-1 Common Paediatric Cancers
Track 7-2 Long-Term Effects of Treatment
Track 7-3 Innovative Therapies
Track 7-4 Supportive Care for Paediatric Patients
Track 7-5 Family and Psychological Support

Session 8: Hematologic Cancer

Hematologic cancer originate in the blood, bone marrow, or lymphatic system and include conditions like leukaemia (affecting blood and bone marrow), lymphoma (affecting the lymphatic system), and multiple myeloma (impacting plasma cells in bone marrow).

Track 8-1 Leukaemia
Track 8-2 Lymphomas
Track 8-3 Multiple Myeloma
Track 8-4 Bone Marrow Disorders
Track 8-5 Advances in Hematologic Treatments

Session 9: Cancer Metastasis

Cancer metastasis is the process through which cancer cells spread from the primary tumour site to other parts of the body. This complex process involves local invasion, entry into the lymphatic or blood circulation, travel to distant organs, and the establishment of secondary tumours at new sites.

Track 9-1 Mechanisms of Metastasis
Track 9-2 Metastatic Sites and Patterns
Track 9-3 Targeting Metastatic Spread
Track 9-4 Role of the Microenvironment
Track 9-5 Experimental Models and Techniques

Session 10: Early Detection and Diagnosis

Early detection and diagnosis are critical for treating cancer in its most manageable stages. This session explores screening techniques like Pap smears, mammograms, and colonoscopies, as well as advanced imaging technologies, such as MRI and CT scans. Innovations like genetic testing and liquid biopsies are further enhancing the ability to detect cancer early with greater accuracy.

Track 10-1 Screening Technique
Track 10-2 Biomarkers in Early Detection
Track 10-3 Imaging Technologies
Track 10-4 Liquid Biopsies
Track 10-5 Genetic Testing and Personalized Diagnosis

Session 11: Drug Development

Drug development for cancer involves identifying, testing, and bringing new cancer therapies to the market. The process begins by pinpointing potential therapeutic targets through genetic and biological research on cancer. Preclinical studies then test the new compound’s safety and effectiveness in lab models before moving into clinical trials, where the treatment's safety, efficacy, and optimal dosage are evaluated in humans.

Track 11-1 Preclinical Testing
Track 11-2 Phase I, II, III Trials
Track 11-3 Regulatory Approval
Track 11-4 Post-Marketing Surveillance
Track 11-5 Drug Repurposing

Session 12: Cancer Prevention

This session addresses strategies aimed at reducing cancer risk through lifestyle and preventative measures. These include adopting healthier habits like balanced nutrition, regular physical activity, and avoiding known carcinogens such as tobacco and excessive alcohol consumption.

Track 12-1 Lifestyle and Environmental Factors
Track 12-2 Vaccination
Track 12-3 Nutritional Interventions
Track 12-4 Public Health Strategies
Track 12-5 Genetic Risk Reduction

Session 13: Cancer and Aging

The relationship between aging and cancer is explored in this session, highlighting that as individual’s age, their risk of cancer increases due to cumulative genetic mutations and weakened cellular repair systems. Older adults face unique challenges in cancer treatment, including managing other health issues and potential side effects.

Track 13-1 Age-Related Cancer Risks
Track 13-2 Geriatric Oncology
Track 13-3 Treatment Considerations in Older Adults
Track 13-4 Survivorship and Aging
Track 13-5 Multidisciplinary Approaches

Session 14: Molecular and Cellular Techniques

This session focuses on advanced methods for studying and manipulating cancer cells at the molecular level to support cancer treatment and research.

Track 14-1 CRISPR and Gene Editing
Track 14-2 Single-Cell Sequencing
Track 14-3 Proteomics and Metabolomics
Track 14-4 High-Throughput Screening
Track 14-5 Bioinformatics Tools

Session 15: Patient-Centred Care

Emphasizing a personalized approach, this session at cancer 2025 explores tailoring care to meet each patient’s specific needs and preferences. It includes creating individualized cancer treatment plans, providing comprehensive support, and fostering patient engagement.

Track 15-1 Quality of Life Assessments
Track 15-2 Palliative and Supportive Care
Track 15-3 Patient-Physician Communication
Track 15-4 Psychosocial Support
Track 15-5 Patient Advocacy and Rights

Session 16: Cancer Epidemiology

Cancer epidemiology examines the patterns, causes, and trends of cancer within populations, including risk factors, geographical differences, and trends in incidence and prevalence.

Track 16-1 Cancer Incidence and Prevalence
Track 16-2 Risk Factors and Correlations
Track 16-3 Geographical Variations
Track 16-4 Surveillance and Monitoring
Track 16-5 Data Collection and Analysis

Session 17: Surgical Oncology

This session covers the surgical removal of cancerous tissues in various cancers, focusing on advanced surgical techniques and innovations. Surgical oncologists may remove tumours, nearby lymph nodes, and some surrounding healthy tissues to achieve optimal outcomes.

Track 17-1 Minimally Invasive Surgery
Track 17-2 Robotic-Assisted Surgery
Track 17-3 Oncological Resections
Track 17-4 Reconstructive Surgery
Track 17-5 Surgical Innovations and Outcomes

Session 18: Radiology in Oncology

Also known as radiation oncology or therapeutic radiology, this field focuses on using radiation treatments to target and manage cancer, along with certain other conditions. In oncology, radiation plays a crucial role in diagnosing and treating cancer by utilizing various forms to destroy cancer cells and prevent their spread.

Track 18-1 Advanced Imaging Techniques
Track 18-2 Interventional Radiology
Track 18-3 Radiomics and Imaging Biomarkers
Track 18-4 Radiotherapy Planning
Track 18-5 Patient Safety and Quality Assurance

Session 19: Cancer Pharmacology

This session explores the study of molecular pathways associated with cell growth and cell death, the action mechanisms of cancer drugs, the development of new therapies, the underlying processes in DNA damage and repair, and advancements in gene therapy strategies.

Track 19-1 Mechanisms of Drug Action
Track 19-2 Pharmacokinetics and Pharmacodynamics
Track 19-3 Toxicity and Side Effects
Track 19-4 Drug Interactions
Track 19-5 Novel Drug Classes

Session 20: Cancer and Nutrition

Nutrition plays a critical role in cancer, influencing cancer risk, the body’s response to treatment, and overall well-being both during and after therapy. This session examines key nutritional factors in cancer prevention and management.

Track 20-1 Nutritional Needs During Treatment
Track 20-2 Impact of Diet on Cancer Progression
Track 20-3 Supplements and Complementary Therapies
Track 20-4 Nutritional Counselling
Track 20-5 Diet and Prevention

Session 21: Cancer Survivorship

Cancer survivorship focuses on providing comprehensive care and support to individuals who have completed cancer treatment. It includes managing lasting side effects, addressing both physical and emotional needs, and monitoring for any recurrence. Survivorship care plans are tailored to guide on going care and promote a healthy lifestyle.

Track 21-1 Long-Term Effects of Cancer Treatment
Track 21-2 Rehabilitation and Recovery
Track 21-3 Survivorship Care Plans
Track 21-4 Mental Health and Wellness
Track 21-5 Community Resources and Support

Session 22: Integrative Oncology

This approach aims to improve patient outcomes by combining conventional cancer therapies with complementary practices. Integrative oncology merges standard treatments with therapies like acupuncture, meditation, and nutritional guidance to address the physical, mental, and emotional needs of the patient.

Track 22-1 Complementary Therapies
Track 22-2 Mind-Body Practices
Track 22-3 Combining Conventional and Alternative Medicine
Track 22-4 Patient Preferences and Efficacy
Track 22-5 Safety and Regulation

Session 23: Health Disparities in Cancer

It refers to the unequal burden and treatment outcomes experienced by different populations, often influenced by race, ethnicity, socioeconomic status, and geographic location. These disparities can impact cancer incidence, survival rates, and access to quality care.

Track 23-1 Access to Care
Track 23-2 Socioeconomic Factors
Track 23-3 Racial and Ethnic Disparities
Track 23-4 Geographic Variations
Track 23-5 Strategies for Equity

Session 24: Global Oncology

Global oncology addresses the differences and challenges in cancer care, prevention, and research across regions. This field promotes global collaboration for sharing knowledge, resources, and strategies aimed at reducing cancer burden worldwide.

Track 24-1 Cancer Burden Worldwide
Track 24-2 International Collaborative Research
Track 24-3 Healthcare Infrastructure
Track 24-4 Global Health Initiatives
Track 24-5 Cultural Considerations in Treatment

Session 25: Future Directions in Oncology

The future of oncology is shaped by advancements in technology and personalized medicine, paving the way for transformative cancer treatments. Emerging areas include the application of machine learning and artificial intelligence for predictive diagnostics, early detection, and optimizing treatment plans.

Track 25-1 Emerging Technologies
Track 25-2 Innovations in Treatment
Track 25-3 Next-Generation Sequencing
Track 25-4 Machine Learning and Artificial Intelligence
Track 25-5 Future Research Trends

Session 26: Case Reports and Case Studies

This session highlights impactful case reports and case studies, providing valuable insights into rare cancer presentations, unique treatment responses, and challenges encountered in cancer management. Through these real-world examples, attendees will gain a deeper understanding of individual patient experiences and the practical application of innovative therapies and interventions. This session will emphasize critical observations that can inspire future research directions and clinical practice improvements.

Track 26-1 Rare and Uncommon Cancer Cases
Track 26-2 Treatment Outcomes and Challenges
Track 26-3 Complications and Adverse Effects in Cancer Therapy
Track 26-4 Personalized and Precision Medicine Cases
Track 26-5 Lessons from Multidisciplinary Cancer Care

Market Analysis

The global oncology drug market was valued at an estimated USD 201.75 billion in 2023, with projections indicating growth from USD 220.80 billion in 2024 to around USD 518.25 billion by 2032.reflecting a compound annual growth rate (CAGR) of 11.3% between 2024 and 2032. This market expansion covers a wide array of cancer treatments, including targeted therapies, chemotherapy, immunotherapy, and hormone therapies. Key factors driving this growth include the rising incidence of cancer, on-going introductions and regulatory approvals of new cancer drugs, and a significant increase in research investments by pharmaceutical companies.

Regional Insights

North America led the oncology drug market in 2023 with a market size of USD 92.65 billion, attributed to rising cancer rates in the U.S. and a strong pipeline of product launches. Data from the American Association for Cancer Research projects that annual cancer diagnoses in the U.S. could approach 2.3 million by 2040.

Europe is expected to hold the second-largest market share, with high-growth countries like the U.K., Germany, France, Italy, and Spain driving this increase due to a rising cancer burden.

The Asia-Pacific region is anticipated to witness rapid growth owing to heightened awareness of cancer, increasing prevalence rates, and greater healthcare investments.

Significant Market Trends

A major trend in the oncology drug market is the expanding use of immunotherapy, a treatment that enhances the body’s immune response against cancer cells. Immunotherapy has shown promising outcomes, particularly for late-stage cancers, with applications across multiple cancer types, such as lung, kidney, bladder, melanoma, cervical, and lymphoma.

Recent research in India has explored the potential benefits of low-dose nivolumab (Opdivo) for advanced head and neck cancer, with findings suggesting that very low doses—around 6% of the standard dosage used in the U.S. and Europe—may extend survival and present a more cost-effective option. Clinical studies in India also explore combining low-dose nivolumab with standard treatments. Rising cancer cases in India are stimulating advancements in diagnostic and therapeutic technologies, contributing to the market's growth in the forecast period.

The forthcoming 4th International Conference on Cancer Research and Treatment, set to take place on April 16-17, 2025, in Dubai, UAE, will bring together international experts to explore these advancements. This event will provide a platform for in-depth discussions on the future of cancer therapy, recent progress in drug development, and regional trends impacting the oncology sector.

Visa Support

To support you in obtaining your visa for the 4th International Conference on Cancer Research and Treatment, taking place on April 16-17, 2025, in Dubai, UAE, we provide a tailored support package to help facilitate your application.

Once you have registered as a speaker or delegate for the conference, you may request the following key documents:

1.Official Invitation Letter: This formal letter confirms your participation in the conference, providing details such as the purpose, dates, and location of the event. It serves as official proof of your intent to attend this prominent academic and educational gathering.

2.Visa Support Letter: This letter is designed to strengthen your visa application by explaining the significance of your participation. It highlights your involvement in activities such as presentations or workshops, emphasizing the academic value and importance of your visit.

3.Payment Confirmation Receipt: This receipt verifies your registration and payment, offering concrete proof of your commitment to attending the conference.

To receive your visa support documents, please complete your registration as a speaker or delegate and send your passport number to our dedicated email addresses: cancer@pulsusgather.com or cancer@alliedgathering.com

Contact

For any help in participating the Cancer 2025 Conference

Gently, contact Program Manager, Marina Jenny via

Email: cancer@pulsusforum.com

WhatsApp: +44-7389644903

(Kindly mention your name as well as the conference name while contacting us)

Alternate Email: cancer@alliedgathering.com

4th International Conference on
Cancer Research and Treatment

Quick Links

Theme: